UNLIMITED FREE ACCESS TO THE WORLD'S BEST IDEAS

close
Already an Engineering360 user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your Engineering360 Experience

close
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

ISO 10993-3

Biological evaluation of medical devices Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity

inactive
Buy Now
Organization: ISO
Publication Date: 15 October 2003
Status: inactive
Page Count: 24
ICS Code (Biological evaluation of medical devices): 11.100.20
scope:

This part of ISO 10993 specifies strategies for hazard identification and tests on medical devices for the following biological aspects:

- genotoxicity,

- carcinogenicity, and

-  reproductive and developmental toxicity.

This part of ISO 10993 is applicable for evaluation of a medical device whose potential for genotoxicity, carcinogenicity or reproductive toxicity has been identified.

NOTE Guidance on selection of tests is provided in ISO 10993-1.

Document History

October 1, 2014
Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
This part of ISO 10993 specifies strategies for risk estimation, selection of hazard identification tests and risk management, with respect to the possibility of the following potentially...
ISO 10993-3
October 15, 2003
Biological evaluation of medical devices Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
This part of ISO 10993 specifies strategies for hazard identification and tests on medical devices for the following biological aspects: — genotoxicity, — carcinogenicity, and —  reproductive and...
January 1, 1992
Biological Evaluation of Medical Devices - Part 3: Tests for Genotoxicity, Carcinogenicity, and Reproductive Toxicity; (CEN EN 30993-3: 1993)
A description is not available for this item.

References

Advertisement